SAN JOSE, Calif., April 28, 2026 (GLOBE NEWSWIRE)-- Prodeon Medical, a medical device company developing minimally invasive treatments for benign prostatic hyperplasia (BPH), today announces that ...
SAN JOSE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prodeon Medical, a medical device company advancing minimally invasive therapies for urologic disease, today announced the first commercial case ...
The Urocross® Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.
Company’s prospective, multi-center 240-patient, pivotal randomized controlled trial (RCT) earns AUA "Practice-changing, Paradigm-shifting Clinical Trials in Urology (P2s)” designation at conference’s ...
(MENAFN- GlobeNewsWire - Nasdaq) First procedure at The Hospital at Westlake Medical Center in Austin, Texas, marks the beginning of the company's controlled U.S. commercial release SAN JOSE, Calif., ...
First procedure at The Hospital at Westlake Medical Center in Austin, Texas, marks the beginning of the company’s controlled U.S. commercial release Dr. Tyler McClintock at Midtown Urology and staff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results